Cargando…
Disease-Specific Non-Reducing End Carbohydrate Biomarkers for Mucopolysaccharidoses
A significant need exists for improved biomarkers for differential diagnosis, prognosis and monitoring of therapeutic interventions for mucopolysaccharidoses (MPS), inherited metabolic disorders that involve lysosomal storage of glycosaminoglycans. Here, we report a simple reliable method based on t...
Autores principales: | Lawrence, Roger, Brown, Jillian R., Al-Mafraji, Kanar, Lamanna, William C., Beitel, James R., Boons, Geert-Jan, Esko, Jeffrey D., Crawford, Brett E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262053/ https://www.ncbi.nlm.nih.gov/pubmed/22231271 http://dx.doi.org/10.1038/nchembio.766 |
Ejemplares similares
-
Bone Biomarkers in Mucopolysaccharidoses
por: Nakamura-Utsunomiya, Akari
Publicado: (2021) -
Glycosaminoglycans as Biomarkers for Mucopolysaccharidoses and Other Disorders
por: Amendum, Paige C., et al.
Publicado: (2021) -
ENT and mucopolysaccharidoses
por: Bianchi, Pier Marco, et al.
Publicado: (2018) -
Diagnosis of Mucopolysaccharidoses
por: Kubaski, Francyne, et al.
Publicado: (2020) -
Glaucoma in mucopolysaccharidoses
por: Kong, Weijing, et al.
Publicado: (2021)